Jones RA - Search Results

1

Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K.

Liu JC, Voisin V, Wang S, Wang DY, Jones RA, Datti A, Uehling D, Al-awar R, Egan SE, Bader GD, Tsao M, Mak TW, Zacksenhaus E. Liu JC, et al. Among authors: jones ra. EMBO Mol Med. 2014 Dec;6(12):1542-60. doi: 10.15252/emmm.201404402. EMBO Mol Med. 2014. PMID: 25330770 Free PMC article.

2

Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.

Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, Weigman VJ, Tsao MS, Lane TF, Perou CM, Zacksenhaus E. Jiang Z, et al. J Clin Invest. 2010 Sep;120(9):3296-309. doi: 10.1172/JCI41490. Epub 2010 Aug 2. J Clin Invest. 2010. PMID: 20679727 Free PMC article.

3

RB1 and p53 at the crossroad of EMT and triple-negative breast cancer.

Jiang Z, Jones R, Liu JC, Deng T, Robinson T, Chung PE, Wang S, Herschkowitz JI, Egan SE, Perou CM, Zacksenhaus E. Jiang Z, et al. Cell Cycle. 2011 May 15;10(10):1563-70. doi: 10.4161/cc.10.10.15703. Epub 2011 May 15. Cell Cycle. 2011. PMID: 21502814 Review.

4

RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation.

Jones RA, Robinson TJ, Liu JC, Shrestha M, Voisin V, Ju Y, Chung PE, Pellecchia G, Fell VL, Bae S, Muthuswamy L, Datti A, Egan SE, Jiang Z, Leone G, Bader GD, Schimmer A, Zacksenhaus E. Jones RA, et al. J Clin Invest. 2016 Oct 3;126(10):3739-3757. doi: 10.1172/JCI81568. Epub 2016 Aug 29. J Clin Invest. 2016. PMID: 27571409 Free PMC article.

5

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.

Liu JC, Granieri L, Shrestha M, Wang DY, Vorobieva I, Rubie EA, Jones R, Ju Y, Pellecchia G, Jiang Z, Palmerini CA, Ben-David Y, Egan SE, Woodgett JR, Bader GD, Datti A, Zacksenhaus E. Liu JC, et al. Cell Rep. 2018 Apr 3;23(1):112-126. doi: 10.1016/j.celrep.2018.03.039. Cell Rep. 2018. PMID: 29617654 Free PMC article.

6

Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation.

Jones RA, Campbell CI, Gunther EJ, Chodosh LA, Petrik JJ, Khokha R, Moorehead RA. Jones RA, et al. Oncogene. 2007 Mar 8;26(11):1636-44. doi: 10.1038/sj.onc.1209955. Epub 2006 Sep 4. Oncogene. 2007. PMID: 16953219

7

The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis.

Jones RA, Moorehead RA. Jones RA, et al. J Mammary Gland Biol Neoplasia. 2008 Dec;13(4):407-13. doi: 10.1007/s10911-008-9097-1. Epub 2008 Nov 11. J Mammary Gland Biol Neoplasia. 2008. PMID: 19002570 Review.

8

IGF-IR mediated mammary tumorigenesis is enhanced during pubertal development.

Jones RA, Watson KL, Campbell CI, Moorehead RA. Jones RA, et al. PLoS One. 2014 Sep 26;9(9):e108781. doi: 10.1371/journal.pone.0108781. eCollection 2014. PLoS One. 2014. PMID: 25259518 Free PMC article.

9

Distinct Requirements for Adaptor Proteins NCK1 and NCK2 in Mammary Gland Development.

Golding AP, Ferrier B, New LA, Lu P, Martin CE, Shata E, Jones RA, Moorehead RA, Jones N. Golding AP, et al. Among authors: jones ra, jones n. J Mammary Gland Biol Neoplasia. 2023 Jul 21;28(1):19. doi: 10.1007/s10911-023-09541-1. J Mammary Gland Biol Neoplasia. 2023. PMID: 37479911 Free PMC article.

10

Reversibility and recurrence of IGF-IR-induced mammary tumors.

Jones RA, Campbell CI, Wood GA, Petrik JJ, Moorehead RA. Jones RA, et al. Oncogene. 2009 May 28;28(21):2152-62. doi: 10.1038/onc.2009.79. Epub 2009 Apr 20. Oncogene. 2009. PMID: 19377512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

965 results

Search Page